
Live Nation “broke the promises they made to the court and to the American People” in 2010 following the company’s merger with Ticketmaster, the United States Department of Justice (DOJ) announced on Tuesday, January 28.
The comments, made by Assistant Attorney General Makan Delrahim of the Justice Department’s Antitrust Division, came as the court entered an Amended Final Judgment extending the consent decree with Live Nation/Ticketmaster by five and a half years.
That consent decree, an antitrust agreement made in 2010, allowed Live Nation to merge with Ticketmaster and included safeguards to prevent anti-competitive behavior in the years following the merger.
It prohibited Live Nation from doing things such as “retaliating” against concert venues for using other ticketing firms, or threatening venues. It was supposed to end this year.
But according to the DOJ, Live Nation “repeatedly” broke the agreement and engaged in conduct that violated the judgment made in 2010.
In December, we reported that the DOJ was “preparing legal action” against Live Nation. The DOJ’s Antitrust Division filed a petition in December asking the court to modify and extend the consent decree, “to put a stop to this conduct and to remove any doubt about defendants’ obligations under the Final Judgment going forward.”
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas